Cargando…
Anti‐human SIRPα antibody is a new tool for cancer immunotherapy
Interaction of signal regulatory protein α (SIRPα) expressed on the surface of macrophages with its ligand CD47 expressed on target cells negatively regulates phagocytosis of the latter cells by the former. We recently showed that blocking Abs to mouse SIRPα enhanced both the Ab‐dependent cellular p...
Autores principales: | Murata, Yoji, Tanaka, Daisuke, Hazama, Daisuke, Yanagita, Tadahiko, Saito, Yasuyuki, Kotani, Takenori, Oldenborg, Per‐Arne, Matozaki, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980332/ https://www.ncbi.nlm.nih.gov/pubmed/29473266 http://dx.doi.org/10.1111/cas.13548 |
Ejemplares similares
-
Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021) -
Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis
por: Okamoto, Takeshi, et al.
Publicado: (2023) -
CD47‐signal regulatory protein α signaling system and its application to cancer immunotherapy
por: Murata, Yoji, et al.
Publicado: (2018) -
Microglial SIRPα regulates the emergence of CD11c(+) microglia and demyelination damage in white matter
por: Sato-Hashimoto, Miho, et al.
Publicado: (2019) -
Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis
por: Matozaki, Takashi, et al.
Publicado: (2020)